arrow_back Back to App

Increased Research and Education for Uterine Fibroids: Better Treatment Options.

This act significantly boosts funding for research into uterine fibroids, a condition affecting millions of women and often leading to major surgery. It mandates new public and medical education programs to speed up diagnosis and promote less invasive, fertility-friendly treatment options. The goal is to improve the quality of life and care, especially for minority groups who face higher risks and more severe symptoms.
Key points
Authorizes $30 million annually (2024-2028) to expand and coordinate research on uterine fibroids to find better treatments.
Establishes public education programs focusing on early diagnosis, elevated risk for minority individuals, and non-hysterectomy treatment options.
Requires data collection on Medicaid and CHIP expenditures for fibroid treatment to assess service coverage and costs.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_2303
Sponsor: Sen. Booker, Cory A. [D-NJ]
Process start date: 2023-07-13
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2023

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_2303.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-07-13.

What are the main provisions?

Key points include:

  • Authorizes $30 million annually (2024-2028) to expand and coordinate research on uterine fibroids to find better treatments.
  • Establishes public education programs focusing on early diagnosis, elevated risk for minority individuals, and non-hysterectomy treatment options.
  • Requires data collection on Medicaid and CHIP expenditures for fibroid treatment to assess service coverage and costs.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Booker, Cory A. [D-NJ].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health